The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study.
about
Brodalumab for the Treatment of Psoriasis: A Review of Phase III TrialsExploring the Physiological Link between Psoriasis and Mood DisordersSelective Phosphodiesterase Inhibitors for Psoriasis: Focus on ApremilastTargeting of interleukin-17 in the treatment of psoriasisPsoriasis and comorbid diseases: Implications for management.Psoriasis and comorbid diseases: Epidemiology.Co-morbidity in psoriasis: mechanisms and implications for treatment.Long-term safety of biologics in the treatment of moderate-to-severe plaque psoriasis: review of current data.The Challenge of Managing Psoriasis: Unmet Medical Needs and Stakeholder Perspectives.Antipsychotic-associated psoriatic rash - a case report.Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.Can stress reduction interventions improve psoriasis? A review.Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR)Use of biologic agents in combination with other therapies for the treatment of psoriasisPsoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasisMalaysian Clinical Practice Guideline for the Management of Psoriasis Vulgaris: Summary of recommendations for management in primary healthcare setting.Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practiceDo eating disorders accompany metabolic syndrome in psoriasis patients? Results of a preliminary studyThe psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countriesDistribution pattern of psoriasis, anxiety and depression as possible causes of sexual dysfunction in patients with moderate to severe psoriasis.Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 BalanceDisease Severity, Quality of Life, and Psychiatric Morbidity in Patients With Psoriasis With Reference to Sociodemographic, Lifestyle, and Clinical Variables: A Prospective, Cross-Sectional Study From Lahore, Pakistan.A multicenter, randomized, open-label pilot trial assessing the efficacy and safety of etanercept 50 mg twice weekly followed by etanercept 25 mg twice weekly, the combination of etanercept 25 mg twice weekly and acitretin, and acitretin alone in paThe challenges of assessing patients' medication beliefs: a qualitative study.Assessment of the Therapeutic Aspect of Systemic Non-Biologic Anti-Psoriatic Treatment Modalities Used in Combination with Methotrexate.Developing a diagnostic checklist of traditional Chinese medicine symptoms and signs for psoriasis: a Delphi studyImprovements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled studyDepression, Anxiety and Stress among Saudi Arabian Dermatology Patients: Cross-sectional studyIncreased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis.An analysis of dermatological quality-of-life scores in relation to psychiatric morbidity in psoriasis.Current and potential immune therapies and vaccines in the management of psoriasis.Prevalence and risk factors of depression in geriatric patients with dermatological diseases.Psychopathological Variables and Sleep Quality in Psoriatic PatientsIncidence rates of suicidal behaviors and treated depression in patients with and without psoriatic arthritis using the Clinical Practice Research DatalinkOptimism as a predictor of health-related quality of life in psoriatics.Illness acceptance degree versus intensity of psychopathological symptoms in patients with psoriasis.Identifying the Zheng in psoriatic patients based on latent class analysis of traditional Chinese medicine symptoms and signs.Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor: A novel treatment option for nurse practitioners treating patients with psoriatic diseaseAlteration of immune markers in a group of melancholic depressed patients and their response to electroconvulsive therapy.Effect of tofacitinib withdrawal and re-treatment on patient-reported outcomes: results from a Phase 3 study in patients with moderate to severe chronic plaque psoriasis.
P2860
Q26746100-FC7461D1-9684-4846-B570-F1F3452B8346Q26778531-E02B2512-0D72-4B79-A0F7-917379F8E37AQ26781755-2CF377F1-CD60-4E65-BB39-860F17319FF7Q27026324-B462BB7D-04E0-43C6-9832-B226654F2524Q30235888-E36B57D2-D465-4A4F-8664-13F2CED74DB5Q30235889-B684C2C1-4AD4-476B-91D6-F6D4589584F0Q30248952-6F0AE7EB-E550-4C41-9FEF-85AF3A504A85Q30574065-8C7A2574-1DCF-4294-B763-699D62517E1FQ33572834-6FD9882C-DE6C-4446-9CF4-D1ACD4F29BB2Q33870010-35A7B798-D1D2-4C2D-A5CD-216D7E58F5E5Q34253312-04972609-EC87-457F-9C6D-593174C99594Q34463708-F5510321-F93A-4790-A733-511EB0C3D8B7Q34516612-82CC8DB7-D774-410F-AAEF-2811751A514EQ34553755-FE785A99-9851-45C8-B975-F4047A53F05AQ34643790-9C023386-1EDB-467F-822D-2420F97E5FD1Q34699605-DCA0E9A0-38A7-454D-8EEE-F6BA79A97531Q34997467-FE16D1D8-E6A7-490C-82D5-B739AD932779Q35212941-67A2CFE5-5D44-4F91-ADCB-4D2CE49487D4Q35228919-70648E52-625B-4E0A-94BA-39E45A4B0B1FQ35892185-BE656992-4AEA-4CCC-A428-8F4752F2FCC9Q36067334-77D8BBE0-7FC7-4E43-B476-E42C0DB7463EQ36083240-58532337-C494-4D4D-B270-60ABB8C276CFQ36085078-823BBB59-93B7-4BDB-83C1-13F1D1C241A4Q36273438-06ECC83F-8BA6-4EB6-9C47-0B1E2322C9FBQ36607070-04B0F2DD-D955-4DF3-9B19-640AF7543CB5Q36863477-6917E5A2-5698-44B9-80A5-A0F729DC4EE2Q36866954-57B9F3B0-365A-4481-A39E-E88B55A13665Q36905188-2F5B812E-4641-477D-9481-B1A17296C46DQ36914874-9FA066F5-A7C8-4FEF-AE97-CC063AB5BE3EQ36950400-53742ECC-A7E8-4289-B69C-B708B6474852Q36977772-6986F19B-1ADF-42EC-876B-56541DA28D64Q37129343-12358DF4-86E8-40D1-A664-4D742DFA9FA4Q37134741-86716919-F017-41E3-ADCD-5660DF0BF567Q37250960-0CD81B31-A8F8-4820-91BF-A5D1205CAECDQ37327130-3B53DEA6-FB36-45B2-ABAE-1B72A635D397Q37327238-473B32D6-4B96-421C-90BD-B52060902178Q37442817-B55A0170-B490-42C9-AA84-FA2AF01A5040Q37505449-7B017517-75F9-49FB-9B3C-D0F6207A8703Q37623631-7B85463C-6B6A-4B92-BC5C-D001B35D5CD9Q37631750-D11AB324-BA82-469C-8B14-284FE7152370
P2860
The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The risk of depression, anxiet ...... population-based cohort study.
@ast
The risk of depression, anxiet ...... population-based cohort study.
@en
The risk of depression, anxiet ...... population-based cohort study.
@nl
type
label
The risk of depression, anxiet ...... population-based cohort study.
@ast
The risk of depression, anxiet ...... population-based cohort study.
@en
The risk of depression, anxiet ...... population-based cohort study.
@nl
prefLabel
The risk of depression, anxiet ...... population-based cohort study.
@ast
The risk of depression, anxiet ...... population-based cohort study.
@en
The risk of depression, anxiet ...... population-based cohort study.
@nl
P2860
P921
P1433
P1476
The risk of depression, anxiet ...... population-based cohort study.
@en
P2093
Paul Crits-Christoph
Shanu Kohli Kurd
P2860
P304
P356
10.1001/ARCHDERMATOL.2010.186
P577
2010-08-01T00:00:00Z